IL-I3 PE38QQR: Updated Phase I/II data

In a Phase I/II trial in 45 patients, IL13-PE38QQR

Read the full 99 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE